Metformin; Heart failure; pre-diabetes; left ventricular mass index
Showing 1 - 25 of >10,000
d to Describe the Filling Phase of the Left Ventricle (LV).
Active, not recruiting
- Diastolic Heart Failure
- +2 more
-
Orlando, FloridaAdventHealth Orlando
Feb 18, 2022
Cardiac Structure and Function in Patients With Cystic Fibrosis
Active, not recruiting
- Cystic Fibrosis
- +12 more
-
Hellerup, Copenhagen, Denmark
- +1 more
Oct 16, 2023
Heart Failure With Preserved Ejection Fraction Trial in Chongqing
Recruiting
- Heart Failure With Preserved Ejection Fraction
-
Chongqing, ChinaThe first affiliated Hospital of Chongqing Medical University
Sep 26, 2021
Heart Failure, Diastolic, Diabetes, Type 2 Trial in Moscow (Empagliflozin, Standard care)
Completed
- Heart Failure, Diastolic
- Diabetes Mellitus, Type 2
- Empagliflozin
- Standard care
-
Moscow, Russian FederationNational Medical Research Center for Cardiology
Jan 10, 2022
Heart Failure With Normal Ejection Fraction, Left Ventricular Hypertrophy, Aortic Valve Stenosis Trial in Boston
Recruiting
- Heart Failure With Normal Ejection Fraction
- +3 more
- 11C-Martinostat
- PET-MRI
-
Boston, MassachusettsMassachusetts General Hospital
Mar 1, 2022
Heart Failure With Reduced Ejection Fraction Trial in Worldwide (Pre-implantation planning, Post-implantation assessment)
Not yet recruiting
- Heart Failure With Reduced Ejection Fraction
- Pre-implantation planning
- Post-implantation assessment
-
Bologna, Italy
- +11 more
Sep 29, 2022
Hypertrophy, Left Ventricular Trial in Worldwide (drug, procedure, radiation)
Active, not recruiting
- Hypertrophy, Left Ventricular
- mirabegron
- +6 more
-
Brussels, Belgium
- +8 more
Sep 28, 2021
Heart Failure, Hypertension, Left Ventricle Remodeling Trial (Empagliflozin 10 MG, Placebo)
Not yet recruiting
- Heart Failure
- +3 more
- Empagliflozin 10 MG
- Placebo
- (no location specified)
Sep 20, 2023
Diabetes, Heart Failure Trial in Los Angeles (Metformin)
Completed
- Diabetes
- Heart Failure
-
Los Angeles, CaliforniaAhmanson-UCLA Cardiomyopathy Center
Aug 20, 2020
Heart-Assist Devices, Heart Failure NYHA Class IV, Exercise Training Trial in Omaha (PREHAB)
Completed
- Heart-Assist Devices
- +2 more
- PREHAB
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Mar 9, 2021
Heart Failure With Reduced Ejection Fraction Trial in Chongqing (Vericiguat)
Not yet recruiting
- Heart Failure With Reduced Ejection Fraction
-
Chongqing, ChinaThe first affiliated Hospital of Chongqing Medical University
Apr 3, 2023
Sodium Glucose Cotransporter 2 Inhibitiors on Left Ventricular
Not yet recruiting
- SGLT2 Inhibitiors Remodeling Effect
- Chronic Heart Disease
- Sodium-glucose cotransporter 2 inhibitor
- (no location specified)
Nov 14, 2023
Diabetes, Type 2, Heart Failure, Diastolic Trial in Houston (Exenatide)
Terminated
- Diabetes Mellitus, Type 2
- Heart Failure, Diastolic
-
Houston, TexasBaylor College of Medicine
Sep 2, 2020
SGLT2 Inhibition in Heart Failure
Recruiting
- Heart Failure
- Sodium-glucose cotransporter 2 inhibitor
-
Belfast, United KingdomBelfast Health and Social Care Trust
Nov 15, 2023
Heart Failure, Heart Failure With Preserved Ejection Fraction, Heart Failure With Mid Range Ejection Fraction Trial
Not yet recruiting
- Heart Failure
- +2 more
- Empagliflozin 10 MG
- (no location specified)
Oct 26, 2022
Heart Failure, Heart Failure With Reduced Ejection Fraction, AV Block Trial (His/LBBP, BiVP)
Not yet recruiting
- Heart Failure
- +6 more
- His/LBBP
- BiVP
- (no location specified)
Dec 6, 2022
Heart Failure, Left Bundle-Branch Block, Cardiac Resynchronization Trial (Conduction system pacing, Biventricular pacing)
Not yet recruiting
- Heart Failure
- +3 more
- Conduction system pacing
- Biventricular pacing
- (no location specified)
Oct 5, 2022
Obesity, Heart Failure Trial (Screening for heart failure)
Not yet recruiting
- Obesity
- Heart Failure
- Screening for heart failure
- (no location specified)
Nov 13, 2023
Kidney Failure, Hemodialysis, Diabetes, Type 2 Trial (Dapagliflozin 10 MG, Placebo)
Not yet recruiting
- Kidney Failure
- +4 more
- Dapagliflozin 10 MG
- Placebo
- (no location specified)
Aug 23, 2022
Diastolic Dysfunction, Obesity Trial in Cairo (Metformin)
Not yet recruiting
- Diastolic Dysfunction
- Obesity
-
Cairo, EgyptCairo University Hospitals
Apr 26, 2023
Dapagliflozin on Cardiorespiratory Parameters in Heart Failure
Recruiting
- Heart Failure
- +4 more
-
Milan, ItalyCentro Cardiologico Monzino
Mar 3, 2023
Heart Failure With Reduced Ejection Fraction, Atrial Fibrillation, Persistent, Sick Sinus Syndrome Trial in Shanghai (Right
Recruiting
- Heart Failure With Reduced Ejection Fraction
- +3 more
- Right heart catheterization
-
Shanghai, Shanghai, ChinaShanghai Tenth People's Hospital
Dec 24, 2022